News
Monthly Archives
Yearly Archives
News
2015 yearly archives
Alexar Therapeutics, Inc. Initiates Phase IIa Clinical Trial for ALX-101 Topical Gel | Nov 23, 2015
Study to Assess Novel Liver X Receptor (LXR) Agonist for the Treatment of Patients with Atopic Dermatitis MALVERN, Pa., Nov …
Alexar Awarded Michael J. Fox Foundation Grant for Research on a Novel Parkinson’s Disease Therapeutic | Jan 23, 2015
Alexar Therapeutics, Inc. announced today that it has been awarded a preclinical research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop Liver X Receptor (LXR) agonists for the treatment of Parkinson’s disease
640 Lee Road, Ste 118,
Wayne, PA 19087
P: 267.465.7565
Email: dpfeiffer@ralexar.com
Legal and Copyright Disclaimer | Privacy Policy
© 2021 Ralexar Therapeutics.
All Rights Reserved.
Web Design & Development time4design - Bucks County Web Design.